Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-04 · accession 0001415889-25-006955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-05 | 2025-03-04 | MIRM | Radovich Peter | Pres AND COO | S - Sale | $45.58 | -14.8K | 12.1K | -55% | -$676.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | S | D | 13,681 | $45.57 | 13,280 | D | — | — | (F1) The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-03-04 | S | D | 1,169 | $45.74 | 12,111 | D | — | — |